• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATH

ALTERITY THERAPEUTICS LIMITED - Charts / Financials

4.00% ! 1.2¢
Market Cap $110.5M  !
Healthcare Biotechnology
Add to My Watchlist

Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company.... Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.59pm 11/09/2025 (20 minute delay) ?
Day
Open 1.2¢   Day High 1.3¢   Day Low 1.2¢
Daily Volume 2408866
Bids   Sellers
Number Price Volume   Number Price Volume
36 1.2¢ 15772214   13 1.3¢ 8854744

Directors & Senior Management

Dr. David A. Stamler Chief Executive Officer
Ms. Abby Macnish Niven Chief Financial Officer, Company Secretary
Mr. Geoffrey Paul Kempler Non-Executive Chairman of the Board
Mr. Lawrence B. Gozlan Non-Executive Director
Mr. Peter Ashley Marks Non-Executive Independent Director
Mr. Brian Derek Meltzer Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.2¢ 		Change
-0.001(4.00%) 		Mkt cap ! $110.5M
Open High Low Value Volume
1.2¢ 1.3¢ 1.2¢ $28.98K 2.408M

Buyers (Bids)

No. Vol. Price($)
36 15772214 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 8854744 13
View Market Depth
Last trade - 16.10pm 11/09/2025 (20 minute delay) ?
Last
1.3¢ 		  Change
-0.001 ( 4.17 %)
Open High Low Volume
1.2¢ 1.3¢ 1.2¢ 7914134
Last updated 15.59pm 11/09/2025 ?

Top Stories

EVR opens strong with funding, acquisition, and sales agreement announcements

EVR has caught attention on the HotCopper forums and across the wider Australian markets today with a flurry of announcements.
Afterpay owner Block shares dip after competitor Klarna lists 30% higher out the gate Afterpay owner Block has seen its shares head towards a -3% drop as the market digests news of Klarna's successful U.S. IPO overnight.
Market Close: Aussie traders divorce from US as retreat continues. At least there's 4DX Good Afternoon and welcome to HotCopper’s Market Close for Thursday 11th of September, I’m Jon Davidson. We’ve truly diverted from Wall Street at the start of September with the local bourse retreating once again this week, showing an Australian inv...
EV Resources snaps up Nevada antimony project; will raise $5.5M for it, Los Lirios EV Resources has come out of its halt with a bang, unveiling the acquisition of the Dollar Antimony Project in Nye County alongside a raise.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.